Projected to reach $6 billion in worldwide revenues by year’s end, the business of advanced wound care has transformed from a sleepy commoditized marketplace to a robust high-growth, hi-tech arena where innovations over the last decade have now become mainstream – at least in the US. Game-changing technologies reinvigorating this space include negative pressure wound therapy (NPWT), pioneered by Kinetic Concepts Inc. (KCI), now part of Acelity LP Inc., supplying a market projected to reach $1.6 billion in 2015; advanced dressings, particularly foam dressing, driven by Swedish company Molnlycke Health Care AB, fueling a $3.2 billion global market; and biologics, starting with skin and dermal substitutes and now including the recently introduced amniotic tissue-derived products by MiMedx Group Inc., creating a market that will exceed $210 million in 2015.
Striking differences in technological approaches for treating hard-to-heal wounds was evident on the exhibit floors at the industry’s two largest...
